An evident view of evidence-based practice in perinatal medicine: Absence of evidence is not evidence of absence;Uma visão evidente da prática baseada em evidências na medicina perinatal: Ausência de evidência não é evidência de ausência

Jornal de Pediatria

Volumn 83, Issue 5, 2007, Pages 395-414

  Sola, Augusto ^a   Dieppa, Fernando Dominguez ^b   Rogido, Marta R ^a  

^a Atlantic Health   (United States)

^b Hospital Ginecoobstetrico Ramon Gonzalez Coro   (Cuba)

Author keywords

Critical reading; Evidence based medicine; Number needed to treat; Outcome variables; Randomized trials; Statistical significance; Treatment effects

Indexed keywords

IRON; MIDAZOLAM; STEROID;

CLAMP; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HUMAN; INTERVENTION STUDY; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; OXIDATION; PERINATAL CARE; POSTNATAL CARE; PREMATURITY; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; UMBILICAL CORD;

EID: 35348942431     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1702     Document Type: Review

References (70)

1. Norman GR, Streiner DL. Biostatistics: the bare essentials. 2nd ed. Hamilton: B.C. Decker; 2000.
2. Michael M, Boyce TW, Wilcox AJ. Biomedical bestiary: an epidemiologic guide to flaws and fallacies in the medical literature. Boston: Little, Brown;1984.
3. Alderson P , Deeks JJ. Concerning: 'The number needed to treat needs an associated odds estimation'. J Public Health (Oxf). 2004;26:400. Author reply in: J Public Health (Oxf). 2004;26:401.
4. Aino H, Yanagisawa S, Kamae I.The number needed to treat needs an associated odds estimation. J Public Health (Oxf). 2004;26:84-7. Erratum in: J Public Health (Oxf). 2004;26:218.
5. Artalejo FR, Banegas JR, Artalejo AR, Guallar-Castillo, P. Number-needed-to treat to prevent one death. Lancet. 1998;351:1365.
6. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310: 452-4.
7. Saver JL. Deriving number-needed-to-treat and number-needed-to-harm from the Saint I trial results. Stroke. 2007;38: 257.
8. de Craen AJ, Vickers AJ, Tijssen JG, Kleijnen J. Number-needed-to-treat and placebo-controlled trials. Lancet. 1998;351: 310.
9. Alderson P, Groves T. What doesn't work and how to show it. BMJ. 2004;328: 473.
10. Hunt A, Millar R. AS science for public understanding. Oxford: Heinemann, 2000.
11. Chalmers I. Well informed uncertainties about the effects of treatments. BMJ. 2004;328: 475-6.
12. Joffe M. "Evidence of absence" can be important. BMJ. 2003;326: 1267.
13. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ. 1995;311: 485.
14. Alderson P, Chalmers I. Survey of claims of no effect in abstracts of Cochrane reviews. BMJ. 2003;326: 475.
15. Altman DG, Bland JM: Confidence intervals illuminate the absence of evidence. BMJ. 2004;328:1016-7.
16. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.N Engl J Med. 2005;353:1574-84.
17. Sinclair JC. Weighing risks and benefits in treating the individual patient. Clin Perinatol. 2003;30: 251-68.
18. Mol A. Proving or improving: on health care research as a form of self-reflection. Qual Health Res. 2006;16:405-14.
19. Des Jarlais DC, Lyles C, Crepaz N; TREND Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94:361-6.
20. Victora CG, Habicht JP, Bryce J. Evidence-based public health: moving beyond randomized trials. Am J Public Health. 2004;94: 400-5.
21. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290: 1624-32.
22. Glasgow RE, Magid DJ, Beck A, Ritzwoller D, Estabrooks PA. Practical clinical trials for translating research to practice: design and measurement recommendations. Med Care. 2005;43: 551-7.
23. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348: 2379-85.
24. Finer NN, Craft A, Vaucher YE, Clark RH, Sola A. Postnatal steroids: short-term gain, long-term pain? J Pediatr. 2000;137: 9-13.
25. Mariani G, Cifuentes J, Carlo WA. Randomized trial of permissive hypercapnia in preterm infants. Pediatrics. 1999;104: 1082-8.
26. Carlo WA, Stark AR, Wright LL, Tyson JE, Papile LA, Shankaran S, et al. Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. J Pediatr. 2002;141: 370-4.
27. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med. 1994;331: 1051-5.
28. Vain NE, Szyld EG, Prudent LM, Wiswell TE, Aguilar AM, Vivas NI. Oropharyngeal and nasopharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: multicentre, randomised controlled trial. Lancet. 2004;364: 597-602.
29. Braekke K, Bechensteen AG, Halvorsen BL, Blomhoff R, Haaland K, Staff AC. Oxidative stress markers and antioxidant status after oral iron supplementation to very low birth weight infants. J Pediatr. 2007;151: 23-8.
30. Hutton EK, Hassan ES. Late vs early clamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials. JAMA. 2007;297: 1241-52.
31. Howard E. Reductions in size and total DNA of cerebrum and cerebellum in adult mice after corticosterone treatment in infancy. Exp Neurol. 1968;22:191-208.
32. Regev R, de Vries LS, Noble-Jamieson CM, Silverman M. Dexamethasone and increased intracranial echogenicity. Lancet. 1987;1: 632-3.
33. Noble-Jamieson CM, Regev R, Silverman M. Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. Eur J Pediatr. 1989;148: 365-7.
34. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 2001;344:95-101.
35. Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics. 2001;107: 217-21.
36. Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr. 2001;1: 1.
37. Gu XQ, Xue J, Haddad GG. Effect of chronically elevated CO2 on CA1 neuronal excitability. Am J Physiol Cell Physiol. 2004;287:C691-7.
38. Martin C, Jones M, Martindale J, Mayhew J. Haemodynamic and neural responses to hypercapnia in the awake rat. Eur J Neurosci. 2006;24: 2601-10.
39. Fritz KI, Zubrow A, Mishra OP, Delivoria-Papadopoulos M. Hypercapnia-induced modifications of neuronal function in the cerebral cortex of newborn piglets. Pediatr Res. 2005;57: 299-304.
40. Kaiser JR, Gauss CH, Pont MM, Williams DK. Hypercapnia during the first 3 days of life is associated with severe intraventricular hemorrhage in very low birth weight infants. J Perinatol. 2006;26: 279-85.
41. Thome UH, Carroll W, Wu TJ, Johnson RB, Roane C, Young D, et al. Outcome of extremely preterm infants randomized at birth to different PaCO2 targets during the first seven days of life. Biol Neonate. 2006;90: 218-25.
42. Sola A, Spitzer A, Morin FC 3rd, Schlueter M, Phibbs RH. Effects of arterial carbon dioxide tension on newborn lamb's cardiovascular response to rapid hemorrhage. Pediatr Res. 1983;17:70-6.
43. Fabres J, Carlo WA, Phillips V, Howard G, Ambalavanan N. Both extremes of arterial carbon dioxide pressure and the magnitude of fluctuations in arterial carbon dioxide pressure are associated with severe intraventricular hemorrhage in preterm infants. Pediatrics. 2007;119: 299-305.
44. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med. 1971;284: 1333-40.
45. Finer NN, Carlo WA, Duara S, Fanaroff AA, Donovan EF, Wright LL, et al . Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics. 2004;114:651-7.
46. Sandri F, Ancora G, Lanzoni A, Tagliabue P, Colnaghi M, Ventura ML, et al. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial. Arch Dis Child Fetal Neonatal Ed. 2004;89:F394-8.
47. Morley C; COIN Trial Investigators. COIN Trial Abstract at PAS Meeting, Toronto, Canada, May 2007.
48. Jobe AH. Iron for preterm infants. J Pediatr. 2007;151:A3.
49. Kling, P J. Iron supplementation in prematurity: how much is too much? J Pediatr. 2007;151:3-4.
50. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004;5: 863-73.
51. Kaur D, Peng J, Chinta SJ, Rajagopalan S, Di Monte DA, Cherny RA, Andersen JK Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging. 2007;28:907-13.
52. Peng J, Peng Li , Stevenson FF, Doctrow SR, Andersen JK. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate Age-related neurodegeneration. J Neurosci. 2007;27:6914-92.
53. Chaparro CM, Neufeld LM, Tena Alavez G, Eguia-Líz Cedillo R, Dewey KG. Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomised controlled trial. Lancet. 2006;367:1997-2004.
54. Anand KJ, Barton BA, McIntosh N, Lagercrantz H, Pelausa E, Young TE, et al. Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial. Neonatal Outcome and Prolonged Analgesia in Neonates. Arch Ped Adol Medicine. 1999;153:331-8.
55. Waisman D, Weintraub Z, Rotschild A, Bental Y Myoclonic movements in very low birth weight premature infants associated with midazolam intravenous bolus administration. Pediatrics. 1999;104:579.
56. Olney JW, Young C, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C. Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci. 2004;25: 135-9.
57. Sinclair JC. Evidence-based therapy in neonatology: distilling the evidence and applying it in practice. Acta Paediatr. 2004;93: 1146-52.
58. Sinclair JC, Haughton DE, Bracken MB, Horbar JD, Soll RF. Cochrane neonatal systematic reviews: a survey of the evidence for neonatal therapies. Clin Perinatol. 2003;30: 285-304.
59. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. 1996. Clin Orthop Relat Res. 2007;455: 3-5.
60. Sacket DL. Patients and therapies: getting the two together. N Engl J Med. 1978;298: 278-9.
61. Sackett DL. Superiority trials, noninferiority trials, and prisoners of the 2-sided null hypothesis. ACP J Club. 2004;140:A11.
62. Chalmers I. Proposal to outlaw the term "negative trial". BMJ. 1985:290:1002.
63. Chalmers I. Well informed uncertainties about the effects of treatment. BMJ. 2004:328:475-6.
64. Fretheim A, Schunemann HJ, Oxman AD. Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines. Health Res Policy Syst. 2006;4:27.
65. Mainland D. Is the difference statistically significant? An innocent request for quack treatment. Clin Pharmacol Ther. 1969;10: 436-8.
66. Mainland D. Statistical ward rounds - 14. "How many patients would we need?Clin Pharmacol Ther. 1969;10:272-81.
67. Mainland D. Medical statistics-thinking vs arithmetic. J Chronic Dis. 1982;35: 413-7.
68. Mainland D. Statistical ritual in clinical journals: is there a cure? - II. Br Med J (Clin Res Ed). 1984;288:920-2.
69. Devereaux PJ, Bhandari M, Clarke M, Montori VM, Cook DJ, Yusuf S, et al. Need for expertise based randomised controlled trials. BMJ. 2005;330: 88.
70. Alderson P. Absence of evidence is not evidence of absence. BMJ. 2004;328: 476-7.